GR1008143B - Φαρμακευτικο σκευασμα περιεχον ενα οξαζολιδινονικο αντιβακτηριακο παραγοντα και μεθοδος για την παρασκευη αυτου - Google Patents

Φαρμακευτικο σκευασμα περιεχον ενα οξαζολιδινονικο αντιβακτηριακο παραγοντα και μεθοδος για την παρασκευη αυτου

Info

Publication number
GR1008143B
GR1008143B GR20130100147A GR20130100147A GR1008143B GR 1008143 B GR1008143 B GR 1008143B GR 20130100147 A GR20130100147 A GR 20130100147A GR 20130100147 A GR20130100147 A GR 20130100147A GR 1008143 B GR1008143 B GR 1008143B
Authority
GR
Greece
Prior art keywords
preparation
oxazolidinonic
same
antibacterial factor
pharmaceutical preparation
Prior art date
Application number
GR20130100147A
Other languages
English (en)
Inventor
Ευθυμιος Χρηστου Κουτρης
Ιωαννα Χρηστου Κουτρη
Αθηνα Γεωργιου Ηλιοπουλου
Αναστασια Λεωνιδα Καλασκανη
Βασιλικη Χρηστου Σαμαρα
Μορφης Νικολαου Αμπατζης
Ευαγγελος Ανδρεα Καραβας
Χριστινα Κιριζιδη
Original Assignee
"Φαρματεν Α.Β.Ε.Ε.",
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Φαρματεν Α.Β.Ε.Ε.", filed Critical "Φαρματεν Α.Β.Ε.Ε.",
Priority to GR20130100147A priority Critical patent/GR1008143B/el
Priority to PCT/EP2014/000605 priority patent/WO2014139657A1/en
Priority to EP14711148.8A priority patent/EP2968170A1/en
Publication of GR1008143B publication Critical patent/GR1008143B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Το παρόν σκεύασμα αφορά στέρεα φαρμακοτεχνική μορφή για χορήγηση διά στόματος αποτελούμενη από θεραπευτικά δραστική ποσότητα ενός αντιβακτηριακού παράγοντα οξαζολιδινόνης και συγκεκριμένα Λινεζολίδη με D90 μικρότερη των 75 μm, η οποία να παρουσιάζει φυσική και χημική σταθερότητα. Επίσης, η εφεύρεση αφορά και μια μέθοδο παρασκευής του ως άνω σκευάσματος.
GR20130100147A 2013-03-11 2013-03-11 Φαρμακευτικο σκευασμα περιεχον ενα οξαζολιδινονικο αντιβακτηριακο παραγοντα και μεθοδος για την παρασκευη αυτου GR1008143B (el)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GR20130100147A GR1008143B (el) 2013-03-11 2013-03-11 Φαρμακευτικο σκευασμα περιεχον ενα οξαζολιδινονικο αντιβακτηριακο παραγοντα και μεθοδος για την παρασκευη αυτου
PCT/EP2014/000605 WO2014139657A1 (en) 2013-03-11 2014-03-10 Pharmaceutical composition containing an oxazolidinone antibacterial agent and method for the preparation thereof
EP14711148.8A EP2968170A1 (en) 2013-03-11 2014-03-10 Pharmaceutical composition containing an oxazolidinone antibacterial agent and method for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100147A GR1008143B (el) 2013-03-11 2013-03-11 Φαρμακευτικο σκευασμα περιεχον ενα οξαζολιδινονικο αντιβακτηριακο παραγοντα και μεθοδος για την παρασκευη αυτου

Publications (1)

Publication Number Publication Date
GR1008143B true GR1008143B (el) 2014-03-14

Family

ID=50336255

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20130100147A GR1008143B (el) 2013-03-11 2013-03-11 Φαρμακευτικο σκευασμα περιεχον ενα οξαζολιδινονικο αντιβακτηριακο παραγοντα και μεθοδος για την παρασκευη αυτου

Country Status (3)

Country Link
EP (1) EP2968170A1 (el)
GR (1) GR1008143B (el)
WO (1) WO2014139657A1 (el)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451345B1 (en) 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
WO2010026597A1 (en) 2008-09-02 2010-03-11 Hetero Research Foundation Oral dosage forms of linezolid and processes for their preparation
CN102885788B (zh) * 2011-07-22 2016-06-29 重庆华邦制药有限公司 一种晶型稳定的利奈唑胺片及其制备方法

Also Published As

Publication number Publication date
WO2014139657A1 (en) 2014-09-18
EP2968170A1 (en) 2016-01-20

Similar Documents

Publication Publication Date Title
MY185221A (en) New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them
MY173258A (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
PH12016501236A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
IL243277B (en) Break-resistant dosage form containing a polymer of ethylene-vinyl acetate
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
MY173259A (en) New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
PH12016500057B1 (en) Novel indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
MX2016015464A (es) Composicion farmaceutica oral de isotretinoina.
EA201590405A1 (ru) Приготовление высушенных липосом для применения в системах выпуска в прессованном виде
MX355730B (es) Proceso para producir medios de cultivo celular.
MY180788A (en) Paste for internal electrode of laminated ceramic capacitor, and laminated ceramic capacitor
IL237688A0 (en) A syringe containing a preparation, in particular a pharmaceutical preparation containing immunoglobulins, a method for its production and use
MX370647B (es) Formulación farmacéutica que tiene estabilidad mejorada.
HUP1600414A2 (hu) Bisoprololt és ramiprilt tartalmazó stabil kombinációs gyógyszerkészítmény
MX2012014970A (es) Composiciones farmaceuticas que comprenden ezetimiba y rosuvastatina de calcio amorfo novedoso.
EP3072512A4 (en) Use of new type of anti-hpv pharmaceutical preparation
PH12016501245A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
EA201500313A1 (ru) Стабилизированная аморфная форма агомелатина, способ ее изготовления и фармацевтические композиции, ее содержащие
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
IN2013MU02528A (el)
MX364541B (es) Composiciones que contienen formación de películas que comprenden acetato de polivinilo y un pigmento.
IN2014KN01768A (el)
GB201307659D0 (en) Preparation of drug particles by micronisation
UA85352U (ru) Фармацевтический продукт, содержащий налбуфин
HK1224569A1 (en) Tamper-resistant dosage form containing ethylene-vinyl acetate polymer

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20140416